BBOX1 and hepatocellular carcinoma: A comparable study has been executed in HCC cells and proved that the lnc-BBOX1-AS1 enhances PHF8-driven autophagy and the resistance of HCC cells to the drug sorafenib by modulating the miRNA-361-3p/PHF8 (Tao et al., 2022).